Singclean was established in Hangzhou, China.
Singclean Medical achieved ISO9001 and ISO 13485 quality management system certifications.
Singcleean Medical was awarded the title of High-tech Enterprise by Hangzhou City.
Singclean Medical was recognized as a High-tech Enterprise of Zhejiang Province.
The Absorbable Hemostatic Particles Project received sponsorship from the national innovation fund.
Singclean Medical granted the title of National High-tech Enterprise.
Established the Nanchang plant.
Singclean Medical received CE certification for Sterile Viscoelastic Solution for Ophthalmic Surgery.
Singclean Medical achieved CE certification for Medical Sodium Hyaluronate Gel for Bone Joint applications.
Ranked #1 in the anti-adhesion field in China.
Established the Sweden branch.
Launched SingLink crosslinking technology.
Achieved CE certification for In Vitro Diagnostic Reagents (HCG, FSH, LH).
Achieved CE certification for Cross-linked Sodium Hyaluronate Gel for Plastic Surgery.
Achieved CE certification for Medical Sodium Hyaluronate Gel for Anti-adhesion.
Achieved CE certification for In Vitro Diagnostic Reagents (MAU).
Singderm featured in the first issue of ASJ, the world-leading aesthetic surgery journal.
Launched the COVID-19 Test Kit (self-testing) with CE1434 certification.
Achieved strong sales in Germany, Czech Republic, Thailand, Brazil, and over 50 countries, with total sales exceeding 170 million units.
Achieved the No. 1 market share in Thailand.
• 58 CE Certificates
• 55 patent certificates
• 3 national or industry product standards